Dapagliflozin/sitagliptin
Medication
From Wikipedia, the free encyclopedia
Dapagliflozin/sitagliptin, sold under the brand name Sidapvia, is a fixed-dose combination anti-diabetic medication used for the treatment of type 2 diabetes.[1] It contains dapagliflozin, as propanediol monohydrate, a SGLT-2 inhibitor; and sitagliptin, as phosphate monohydrate, a DPP-4 inhibitor.[1] It is taken by mouth.[1]
Trade namesSidapvia
Pregnancy
category
category
- AU: D[1]
| Combination of | |
|---|---|
| Dapagliflozin | SGLT-2 inhibitor |
| Sitagliptin | DPP-4 inhibitor |
| Clinical data | |
| Trade names | Sidapvia |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
